Written by students who passed Immediately available after payment Read online or as PDF Wrong document? Swap it for free 4.6 TrustPilot
logo-home
Exam (elaborations)

WGU D027 ADVANCED PATHOPHARMACOLOGICAL FOUNDATIONS FINAL EXAM 2026/2027 | Complete Study Guide | 100% Correct Verified Answers | Pass Guaranteed - A+ Graded

Rating
-
Sold
-
Pages
42
Grade
A+
Uploaded on
28-05-2026
Written in
2025/2026

Pass the WGU D027 Advanced Pathopharmacological Foundations Final Exam on your first attempt with this complete 2026/2027 study guide featuring 100% correct verified answers. This A+ Graded resource is a comprehensive final exam study guide containing 100% correct verified answers covering every advanced pathopharmacology domain required for final exam mastery. Section 1: Foundational Pathophysiology – cellular adaptation, injury, necrosis, apoptosis, inflammation and immune response mechanisms, genetics and genomics in disease, neoplasia and cancer biology, fluid and electrolyte imbalances, acid-base disorders and compensation mechanisms. Section 2: Foundational Pharmacology – pharmacokinetics (absorption, distribution, metabolism, excretion), pharmacodynamics (receptor theory, dose-response curves, therapeutic index, potency, efficacy), adverse drug reactions and medication safety, drug-drug and drug-food interactions, polypharmacy risks, pharmacogenomics and genetic variations, personalized medicine applications. Section 3: Cardiovascular System – hypertension pathology and antihypertensive drug classes (ACE inhibitors, ARBs, beta-blockers, calcium channel blockers, diuretics), heart failure pathophysiology and treatment guidelines (digoxin, diuretics, beta-blockers, ACE inhibitors, ARNI), coronary artery disease and antianginal agents (nitrates, beta-blockers, calcium channel blockers), dyslipidemias and lipid-lowering medications (statins, fibrates, niacin, ezetimibe, PCSK9 inhibitors), arrhythmias and antiarrhythmic drug classifications (Class I-IV). Section 4: Respiratory System – COPD pathology and pharmacotherapy (bronchodilators, corticosteroids, roflumilast), asthma pathophysiology and stepwise pharmacotherapy (SABA, LABA, ICS, leukotriene modifiers, monoclonal antibodies), pulmonary hypertension treatments. Section 5: Renal and Urinary System – acute kidney injury and chronic kidney disease pathophysiology, drug dosing adjustments based on GFR, diuretic classifications and mechanisms, glomerulonephritis and pharmacotherapy. Section 6: Gastrointestinal System – GERD, PUD, IBD (Crohn's, UC), cirrhosis, pancreatitis – pathophysiology and medication management (PPIs, H2 blockers, antacids, 5-ASA, immunomodulators, biologics). Section 7: Endocrine System – diabetes mellitus Type 1 and Type 2 pathophysiology, insulin preparations (rapid, short, intermediate, long-acting), oral hypoglycemics (metformin, sulfonylureas, TZDs, DPP-4 inhibitors, SGLT2 inhibitors, GLP-1 agonists), thyroid disorders (hypothyroidism: levothyroxine; hyperthyroidism: methimazole, PTU), adrenal disorders (corticosteroid therapy). Section 8: Neurologic System – stroke pathophysiology and acute management (tPA, antiplatelets), seizure disorders and anticonvulsant drugs (phenytoin, valproate, levetiracetam, lamotrigine), Parkinson's disease and dopaminergic agents (levodopa/carbidopa, dopamine agonists), Alzheimer's disease (cholinesterase inhibitors, memantine), multiple sclerosis disease-modifying therapies. Section 9: Psychiatric Disorders – depression and antidepressant classes (SSRIs, SNRIs, MAOIs, TCAs, atypical antidepressants), anxiety disorders and anxiolytics (benzodiazepines, buspirone, SSRIs), bipolar disorder and mood stabilizers (lithium, valproate, lamotrigine, carbamazepine), schizophrenia and antipsychotic agents (typical first-generation, atypical second-generation). Section 10: Hematologic System – anemias and treatments (iron, B12, folate, erythropoietin), coagulopathies and anticoagulant/antiplatelet therapies (warfarin, heparin, DOACs, aspirin, clopidogrel), thrombosis pathophysiology. Section 11: Immunologic System – autoimmune disease pathogenesis, immunosuppressants (corticosteroids, calcineurin inhibitors, antimetabolites, biologics), hypersensitivity reactions, immunodeficiencies. Section 12: Musculoskeletal System – osteoporosis pharmacotherapy (bisphosphonates, denosumab, teriparatide, raloxifene), osteoarthritis treatment (acetaminophen, NSAIDs, intra-articular injections), rheumatoid arthritis (DMARDs: methotrexate, biologics, JAK inhibitors), gout management (colchicine, NSAIDs, allopurinol, febuxostat). Section 13: Infectious Diseases – antimicrobial therapies: antibiotics by mechanism/class (penicillins, cephalosporins, macrolides, tetracyclines, aminoglycosides, fluoroquinolones, sulfonamides), antivirals, antifungals, antiparasitics, antimicrobial resistance principles and stewardship. Section 14: Special Populations – pediatric pharmacokinetic/pharmacodynamic considerations, geriatric pharmacotherapy challenges, pregnancy/lactation medication safety, hepatic impairment drug adjustments, renal impairment drug dosing. Each answer includes detailed pathophysiological and pharmacological rationales to reinforce clinical reasoning for final exam success. Perfect for advanced practice nursing students and graduate-level learners. With our Pass Guarantee, you can confidently pass your WGU D027 Final Exam. Download your complete WGU D027 Final Exam Study Guide instantly!

Show more Read less
Institution
WGU D027 ADVANCED PATHOPHARMACOLOGICAL FOUNDATIONS
Course
WGU D027 ADVANCED PATHOPHARMACOLOGICAL FOUNDATIONS

Content preview

1



WGU D027 ADVANCED PATHOPHARMACOLOGICAL
FOUNDATIONS FINAL EXAM 2026/2027 | Complete Study
Guide | 100% Correct Verified Answers | Pass Guaranteed -
A+ Graded


[Section 1: Cellular Pathophysiology, Genetics & Epigenetics (Q1-10)]

Q1. A 68-year-old patient presents with crushing chest pain and is found to have an
acute ST-elevation myocardial infarction. Within hours, the affected myocardial tissue
shows preserved tissue architecture with loss of nuclei and eosinophilic cytoplasm.
Which pattern of necrosis is described?

A. Liquefactive necrosis
B. Caseous necrosis
C. Coagulative necrosis
D. Fat necrosis

Correct Answer: C Rationale: C. Coagulative necrosis [CORRECT] — Coagulative
necrosis is characteristic of ischemic injury in solid organs with high protein content
(heart, kidney, spleen) where tissue architecture is preserved initially due to
denaturation of structural proteins. Liquefactive necrosis occurs in the brain and
abscesses, caseous necrosis is seen in tuberculosis, and fat necrosis is associated with
pancreatic enzyme release.

Q2. A patient with sepsis develops widespread cell death characterized by cell
swelling, plasma membrane rupture, and release of intracellular contents that trigger
intense inflammation. Which cell death mechanism is most likely involved?

A. Apoptosis
B. Pyroptosis
C. Autophagy
D. Necroptosis

Correct Answer: D Rationale: D. Necroptosis [CORRECT] — Necroptosis is a
regulated form of necrotic cell death mediated by RIPK1/RIPK3 and MLKL that results
in membrane rupture and inflammatory cytokine release, commonly seen in sepsis,
ischemia-reperfusion, and viral infections. Apoptosis is non-inflammatory, pyroptosis

,2



involves caspase-1 and inflammasomes (IL-1β/IL-18 release), and autophagy is
primarily a survival mechanism.

Q3. A 25-year-old man is diagnosed with Huntington's disease. His father also had
the disease, but his mother did not. Which inheritance pattern is demonstrated?

A. Autosomal recessive
B. Autosomal dominant
C. X-linked recessive
D. Mitochondrial

Correct Answer: B Rationale: B. Autosomal dominant [CORRECT] — Huntington's
disease is an autosomal dominant disorder caused by CAG trinucleotide repeat
expansion in the HTT gene on chromosome 4. Affected individuals have a 50%
chance of transmitting the mutation to each offspring. The paternal transmission
history and vertical inheritance pattern confirm autosomal dominant inheritance.

Q4. A newborn has a weak cry resembling a cat's meow, microcephaly, and severe
intellectual disability. Karyotyping reveals deletion of the short arm of chromosome
5. Which chromosomal disorder is present?

A. Cri-du-chat syndrome
B. Prader-Willi syndrome
C. Turner syndrome
D. Klinefelter syndrome

Correct Answer: A Rationale: A. Cri-du-chat syndrome [CORRECT] — Cri-du-chat
syndrome (5p deletion syndrome) is characterized by a distinctive cat-like cry,
microcephaly, severe intellectual disability, and round facies in infancy. Prader-Willi
involves 15q11.2 deletion or UPD, Turner is 45,X, and Klinefelter is 47,XXY.

Q5. A child with Prader-Willi syndrome has obesity, hypotonia, and intellectual
disability. Genetic testing shows no deletion on chromosome 15q11.2. Which
alternative mechanism explains this presentation?

A. X-linked inheritance
B. Uniparental disomy (maternal UPD 15)
C. Chromosomal translocation
D. Mitochondrial heteroplasmy

,3



Correct Answer: B Rationale: B. Uniparental disomy (maternal UPD 15) [CORRECT]
— Prader-Willi syndrome can result from paternal deletion of 15q11.2 (70%),
maternal uniparental disomy (25-30%), or imprinting defects. Maternal UPD 15
causes PWS because the paternally expressed genes on 15q11.2 are silenced on the
maternal chromosome due to genomic imprinting.

Q6. A patient with chronic myeloid leukemia has the Philadelphia chromosome,
t(9;22)(q34;q11). Which type of chromosomal abnormality is this?

A. Deletion
B. Duplication
C. Reciprocal translocation
D. Inversion

Correct Answer: C Rationale: C. Reciprocal translocation [CORRECT] — The
Philadelphia chromosome results from a reciprocal translocation between
chromosomes 9 and 22, creating the BCR-ABL fusion gene that produces a
constitutively active tyrosine kinase. This is a hallmark of CML and some cases of ALL.

Q7. A tumor suppressor gene is silenced in a cancer cell without any mutation in the
DNA sequence. Hypermethylation of CpG islands in the promoter region is identified.
Which epigenetic mechanism is responsible?

A. Histone acetylation
B. DNA methylation
C. Histone phosphorylation
D. Chromosomal translocation

Correct Answer: B Rationale: B. DNA methylation [CORRECT] — DNA methylation
at CpG islands in promoter regions is a key epigenetic mechanism of transcriptional
silencing. Hypermethylation of tumor suppressor gene promoters is a common
oncogenic event. Histone acetylation generally activates transcription, while
phosphorylation and translocation are unrelated to this specific silencing mechanism.

Q8. A microRNA (miRNA) binds to the 3' untranslated region of a target mRNA,
leading to mRNA degradation and translational repression. Which level of gene
regulation does this represent?

A. Transcriptional regulation
B. Post-transcriptional regulation

, 4



C. Translational regulation only
D. Post-translational modification

Correct Answer: B Rationale: B. Post-transcriptional regulation [CORRECT] —
miRNAs are small non-coding RNAs that regulate gene expression post-
transcriptionally by binding to complementary sequences on target mRNAs, causing
degradation or blocking translation. This occurs after transcription but before or
during protein synthesis.

Q9. A patient with cystic fibrosis has two different CFTR mutations: one common
deletion (ΔF508) and one rare missense mutation. Which term describes this genetic
state?

A. Homozygous
B. Compound heterozygous
C. Hemizygous
D. Heteroplasmy

Correct Answer: B Rationale: B. Compound heterozygous [CORRECT] — Cystic
fibrosis is autosomal recessive. A compound heterozygote has two different mutant
alleles at the same locus (e.g., ΔF508 and a rare missense mutation). Homozygous
would require identical mutations, hemizygous applies to X-linked genes in males,
and heteroplasmy refers to mixed mitochondrial DNA populations.

Q10. Inflammasome activation leads to caspase-1-mediated cleavage of pro-IL-1β
and pro-IL-18, followed by pyroptotic cell death. Which pattern recognition receptor
is most commonly associated with NLRP3 inflammasome activation?

A. TLR4
B. NOD2
C. NLRP3
D. RIG-I

Correct Answer: C Rationale: C. NLRP3 [CORRECT] — The NLRP3 inflammasome is
activated by diverse danger signals (ATP, uric acid crystals, silica, asbestos, bacterial
toxins) and leads to caspase-1 activation, IL-1β/IL-18 maturation, and gasdermin D-
mediated pyroptosis. TLR4 is a membrane-bound pattern recognition receptor,
NOD2 senses bacterial peptidoglycan, and RIG-I detects viral RNA.

[Section 2: Pharmacokinetics, Pharmacodynamics & Pharmacogenomics (Q11-18)]

Written for

Institution
WGU D027 ADVANCED PATHOPHARMACOLOGICAL FOUNDATIONS
Course
WGU D027 ADVANCED PATHOPHARMACOLOGICAL FOUNDATIONS

Document information

Uploaded on
May 28, 2026
Number of pages
42
Written in
2025/2026
Type
Exam (elaborations)
Contains
Questions & answers

Subjects

  • how to pass wgu d

Get to know the seller

Seller avatar
Reputation scores are based on the amount of documents a seller has sold for a fee and the reviews they have received for those documents. There are three levels: Bronze, Silver and Gold. The better the reputation, the more your can rely on the quality of the sellers work.
BESTSELLERSTUVIA01 Chamberlain College Of Nursing
View profile
Follow You need to be logged in order to follow users or courses
Sold
551
Member since
3 year
Number of followers
255
Documents
4945
Last sold
3 hours ago
BESTSELLERSTUVIA01

Welcome to Bestsellerstuvia01! I provide high-quality nursing study resources designed to help students prepare with confidence for exams and coursework. My collection includes comprehensive study guides, practice questions, exam reviews, summaries, and learning materials covering a wide range of nursing programs and subjects. Resources are available for NCLEX-RN, NCLEX-PN, ATI (including TEAS 7), HESI, ANCC, WGU nursing programs, and many other nursing courses such as Fundamentals, Medical-Surgical Nursing, Pharmacology, Mental Health, Maternal-Newborn, Pediatrics, Leadership, Community Health, Pathophysiology, Nutrition, Dosage Calculations, Critical Care, and more. My goal is to provide organized, accurate, and easy-to-understand materials that support effective learning and exam preparation. Whether you're preparing for an entrance exam, course exam, competency assessment, or licensure exam, you'll find resources to help you study more efficiently. If you're looking for a specific nursing resource that isn't currently listed, feel free to contact me. Email:

Read more Read less
3.7

103 reviews

5
48
4
17
3
16
2
5
1
17

Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their tests and reviewed by others who've used these notes.

Didn't get what you expected? Choose another document

No worries! You can instantly pick a different document that better fits what you're looking for.

Pay as you like, start learning right away

No subscription, no commitments. Pay the way you're used to via credit card and download your PDF document instantly.

Student with book image

“Bought, downloaded, and aced it. It really can be that simple.”

Alisha Student

Working on your references?

Create accurate citations in APA, MLA and Harvard with our free citation generator.

Working on your references?

Frequently asked questions